Page 171 - Educacional Ponenecias Congreso SEHH-STH 2020
P. 171

derstanding of clinical events and their potential Implications.Am J Hematol.
2012 March;87(3):340-6.
30. Álvarez O, Rodríguez MM, Jordan L, Sarnaik S. Renal medullary carci-
noma and sickle cell trait: a systematic review. Pediatr Blood Cancer.
2015;62(10):1694-9.
31. Naik RP, Derebail VK, Grams ME, Franceschini N, Auer PL, Peloso GM, et al.
Association of sickle cell trait with chronic kidney disease and albuminuria in
African Americans. JAMA. 2014;312:2115-25.
32. Naik RP, Irvin MR, Judd S, Gutiérrez OM, Zakai NA, Derebail VK, et al. Sickle cell
trait and the risk of ESRD in blacks. J Am Soc Nephrol. 2017;28:2180-7.
33. Raffield LM, Ulirsch JC, Naik RP, Lessard S, Handsaker RE, Jain D, et al.; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Hema- tology & Hemostasis, Diabetes, and Structural Variation TOPMed Work- ing Groups. Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease. PLoS Genet. 2018 Mar
28;14(3):e1007293.
34. Goodman J,Hassell K,Irwin D,Witkowski EH,Nuss R.The splenic syndrome in
individuals with sickle cell trait. High Alt Med Biol. 2014;15(4):468-71.
35. Kaplowitz K, Nobe M, Abazari A, Honkanen R. Trabeculectomy for traumatic
hyphema in sickle cell trait. Semin Ophthalmol. 2015;30:297-304.
36. Matta A, Tandra PK, Berim L. Priapism in a patient with sickle cell trait using
marijuana. BMJ Case Rep. 2014;2014:bcr2014204199.
37. Folsom AR, Tang W, Roetker NS, Kshirsagar AV, Derebail VK, Lutsey PL, et al. Prospective study of sickle cell trait and venous thromboembolism incidence.
J Thromb Haemost. 2015;13(1):2-9.
38. Naik RP,Wilson JG,Ekunwe L,Mwasongwe S,Duan Q,LiY,et al.Elevated D-dimer levels in African Americans with sickle cell trait. Blood. 2016;127(18):2261-3. 39. Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, et al. Clinical Outcomes Associated With Sickle Cell Trait: a Systematic Re-
view. Ann Intern Med. 2018;169(9):619-27.
40. Lee ST, Weykamp CW, Lee YW, Kim JW, Ki CS. Effects of 7 hemoglobin vari-
ants on the measurement of glycohemoglobin by 14 analytical methods.
Clin Chem. 2007;53:2202-5.
41. Gozal D, Lorey FW, Chandler D, Derry MK, Lisbin A, Keens TG, et al. Incidence
of sudden infant death syndrome in infants with sickle cell trait. J Pediatr.
1994;124:211-4.
42. Wellenstein WL, Sullivan S, Darbinian J, Ritterman Weintraub ML, Greenberg
M. Adverse Pregnancy Outcomes in Women with Sickle Cell Trait. AJP Rep.
2019;9(4):e346-e352.
43. Wilson S, Ellsworth P, Key NS. Pregnancy in Sickle Cell Trait: What We Do and
Don’t Know. Br J Haematol. 2020;190(3):328-35.
44. Amar KO, Bourdonné O, Bruneau S, Sellami F, Richard P. Assessment of leu-
coreduction of sickle cell trait blood: quality of the filtered product. Blood
Transfus. 2014;12 Suppl 1(Suppl 1):s193-s198.
45. Fitzhugh CD, Hsieh MM, Bolan CD, Saenz C, Tisdale JF. Granulocyte colony-
stimulating factor (G-CSF) administration in individuals with sickle cell dis-
ease: time for a moratorium?. Cytotherapy. 2009;11(4):464-71.
46. Reese PP, Hoo AC, Magee CC. Screening for sickle trait among potential live kidney donors: policies and practices in US transplant centers. Transpl Int.
2008;21(4):328-31.
 LXII Congreso Nacional de la Sociedad Española de Hematología y Hemoterapia / Ponencias
 171
























































   169   170   171   172   173